An observational study in Hirsutism and PCOS, sponsored by Odense University Hospital. Status unknown at 1 site in Denmark. Open to female participants aged 15 Years to 50 Years. Per ClinicalTrials.gov, last updated 2011-04-19.
Sponsored by Odense University Hospital · Observational
All newly referred patients with PCOS and hirsutism are listed in a database.
All premenopausal women referred to the outpatient clinic at the Department of Endocrinology from 1997 and onward with the referral diagnoses hirsutism and/or PCOS are included in a clinical database. The patients should fulfill the Rotterdam criteria for PCOS or have clinical/biochemical hyperandrogenemia.
Routine evaluation include medical history, clinical examination, transvaginal ultrasound (US), and fasting blood samples. Cycle history is recorded in all patients using a standard scheme prepared for hirsute patients. Blood tests include androgens, LH, FSH, prolactin, and lipid profile.
OGTT and ACTH are performed in high risk patients
41 studies on the registry are indexed under Hirsutism; 8 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 206 across 14 observational studies indexed under Hirsutism.
Browse Hirsutism studies →Odense University Hospital is the lead sponsor of 479 studies on the registry; 110 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Premenopausal women referred with hirsutism or PCOS to Odense University hospital
Inclusion Criteria:
The record gives a start of Jan 1997, a primary completion of Jan 2020 and a completion of Jan 2020. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jan 1997. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.